Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$592M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$432M |
| 3 |
CRH
CRH
|
+$395M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$231M |
| 5 |
Intel
INTC
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$558M |
| 2 |
Apple
AAPL
|
+$477M |
| 3 |
NVIDIA
NVDA
|
+$462M |
| 4 |
Microsoft
MSFT
|
+$444M |
| 5 |
Eli Lilly
LLY
|
+$299M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.42% |
| 2 | Healthcare | 12.89% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Amylyx Pharmaceuticals
AMLX
$2.41B
| $3M | ﹤0.01% |
163,595
-286
| -0.2% | -$6.05K |
|
2577
Camden National
CAC
$993M
| $2.99M | ﹤0.01% |
105,982
-705
| -0.7% | -$22.8K |
|
2578
Lifestance Health
LFST
$4.75B
| $2.99M | ﹤0.01% |
435,147
-6,315
| -1% | -$51.2K |
|
|
GOOD
2579
Gladstone Commercial Corp
GOOD
$626M
| $2.99M | ﹤0.01% |
245,782
+5,875
| +2% | +$77.1K |
|
|
ECHO
2580
EchoStar
ECHO
$26.7B
| $2.99M | ﹤0.01% |
178,405
+4,766
| +3% | +$90.1K |
|
2581
Forrester Research
FORR
$217M
| $2.97M | ﹤0.01% |
102,792
-6,416
| -6% | -$197K |
|
|
ETWO
2582
DELISTED
E2open Parent Holdings
ETWO
| $2.97M | ﹤0.01% |
654,153
-74,379
| -10% | -$368K |
|
2583
Regional Management Corp
RM
$309M
| $2.97M | ﹤0.01% |
107,125
+3,737
| +4% | +$111K |
|
2584
RxSight
RXST
$287M
| $2.96M | ﹤0.01% |
106,203
+3,132
| +3% | +$93.4K |
|
|
INFN
2585
DELISTED
Infinera Corporation Common Stock
INFN
| $2.95M | ﹤0.01% |
704,861
+1,474
| +0.2% | +$6.36K |
|
|
HA
2586
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.94M | ﹤0.01% |
464,969
-37,034
| -7% | -$351K |
|
2587
Life Time Group Holdings
LTH
$10.1B
| $2.94M | ﹤0.01% |
193,462
-16,094
| -8% | -$284K |
|
2588
Dole
DOLE
$1.26B
| $2.94M | ﹤0.01% |
253,885
+33,228
| +15% | +$415K |
|
2589
Clearfield
CLFD
$391M
| $2.93M | ﹤0.01% |
102,381
+819
| +0.8% | +$32.1K |
|
2590
Oscar Health
OSCR
$10.1B
| $2.91M | ﹤0.01% |
522,261
-22,163
| -4% | -$155K |
|
2591
Amneal Pharmaceuticals
AMRX
$6.32B
| $2.9M | ﹤0.01% |
688,362
+60,024
| +10% | +$224K |
|
2592
Intapp
INTA
$3.09B
| $2.89M | ﹤0.01% |
86,163
+18,592
| +28% | +$679K |
|
2593
Zai Lab
ZLAB
$2.91B
| $2.89M | ﹤0.01% |
118,792
-157
| -0.1% | -$4.18K |
|
2594
ADMA Biologics
ADMA
$2.12B
| $2.88M | ﹤0.01% |
805,700
+16,551
| +2% | +$63.7K |
|
2595
Community Health Systems
CYH
$423M
| $2.88M | ﹤0.01% |
994,443
-73,428
| -7% | -$272K |
|
2596
Amalgamated Financial
AMAL
$1.53B
| $2.88M | ﹤0.01% |
167,441
+42,171
| +34% | +$763K |
|
2597
Alta Equipment Group
ALTG
$237M
| $2.88M | ﹤0.01% |
238,424
+13,036
| +6% | +$195K |
|
2598
Brookdale Senior Living
BKD
$3.02B
| $2.88M | ﹤0.01% |
694,535
+17,310
| +3% | +$69.5K |
|
2599
indie Semiconductor
INDI
$995M
| $2.87M | ﹤0.01% |
456,337
+18,235
| +4% | +$141K |
|
2600
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.55B
| $2.87M | ﹤0.01% |
94,371
+22,163
| +31% | +$695K |
|
Similar funds
Bank of New York Mellon's Q3 2023 Portfolio in Review
As of Q3 2023, Bank of New York Mellon held 4,503 positions worth $455B, down 4.5% from $476B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q3 2023 filing shows 126 new, 1,681 increased, 2,220 reduced and 160 closed positions. Its largest new stake was Invesco S&P 500 Quality ETF: 1,449,432 shares worth $72.5M. The largest sale was ExxonMobil, an estimated $558M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2023 buy was Invesco S&P 500 Quality ETF: 1,449,432 shares worth $72.5M.
- Bank of New York Mellon added most to Kenvue in Q3 2023, an estimated $592M increase.
- Bank of New York Mellon's biggest Q3 2023 reduction was ExxonMobil, cutting an estimated $558M.
- Bank of New York Mellon fully exited Life Storage, Inc. in Q3 2023, selling an estimated $131M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $455B portfolio in Q3 2023.
- Bank of New York Mellon opened 126 new positions and closed 160 in Q3 2023.
- Bank of New York Mellon's portfolio value fell 4.5% quarter-over-quarter to $455B.
Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.